Novel tests improve diagnosis of two types of liver cancer

New data from two clinical trials presented at the International Liver Congress 2013 demonstrated substantial improvements in the detection of both HCC and cholangiocarcinoma using diagnostic urine tests.

Cetuximab enables liver metastasis surgery in colorectal cancer

Combining cetuximab (Erbitux) with standard therapy improved the resectability of previously inoperable liver metastases of colorectal cancer.

Measuring hepatic function can be used to plan treatment for liver cancer patients

Monitoring the hepatic function of unresectable liver cancer patients provides vital information that could guide more customized treatment plans and reduce risks of liver injury.

Heart drugs turn cancer cells into anticancer vaccines

Plant-based drugs primarily used in the treatment of heart failure and arrhythmias have now been found to exert anticancer effects.

Vitamin E intake inversely linked to liver cancer risk

Vitamin E from diet or supplements may reduce the risk of developing liver cancer.

Weight and inactivity impact cancer rates

Overall US cancer death rates have continued to decline since the early 1990s, but excess weight and lack of sufficient activity contribute to the increased incidence of many cancers.

Thiazolidinediones tied to lower cancer risk in diabetes patients

Pioglitazone, rosiglitazone linked to lower liver cancer risk; rosiglitazone tied to lower CRC risk.

Side effects of certain cancer drugs may be fatal

Sorafenib, sunitinib, and pazopanib have been found to carry a heightened risk of fatal complications, but the incidence remains low overall.

Clinical Trial: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer

Clinical Trial: Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot be Removed by Surgery or Transplant

Clinical Trial: Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis